Page last updated: 2024-10-21

5-hydroxydecanoate and Pulmonary Hypertension

5-hydroxydecanoate has been researched along with Pulmonary Hypertension in 2 studies

5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, L1
Li, Y2
Hu, H1
Shi, L1
Chen, J1
Wang, B1
Chen, C2
Zhu, H1
Li, Q2
Zhang, L1
Shu, Y1
Li, YL1
Zhang, LP1
Chen, CS1

Other Studies

2 other studies available for 5-hydroxydecanoate and Pulmonary Hypertension

ArticleYear
Potential therapeutic targets for hypoxia-induced pulmonary artery hypertension.
    Journal of translational medicine, 2014, Feb-08, Volume: 12

    Topics: Animals; Blood Pressure; Cell Proliferation; Chemokine CCL2; Decanoic Acids; Hydroxy Acids; Hyperten

2014
[The effect of 5-HD on expression of PKC-alpha in rats of chronic hypoxic pulmonary hypertension].
    Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2011, Volume: 27, Issue:3

    Topics: Animals; Decanoic Acids; Hydroxy Acids; Hypertension, Pulmonary; Hypoxia; Male; Muscle, Smooth, Vasc

2011